-
Targeting HCWs for all ACIP recommended shots
-
A broad array of new federal regulations on health care associated infections (HAIs) continue to come on line in 2014 and beyond, tying infection prevention more directly to the hospital bottom line than at any time in the field's history.
-
Of all the motivations to become an infectious disease doctor, this is one of the more unusual paths taken: lose most of one leg and nearly all of your life to a series of recurrent near pan-resistant bacterial infections that you've finally fought into remission but still have a 30% chance of coming back and trying to kill you.
-
-
-
For years scarce data on health care associated infections in long term care has been extrapolated from small studies and published reports, but a new era of infection prevention is opening that may eventually produce the kind of benchmarking and national comparative HAI rates used in hospitals.
-
Pick your poison: Hypervirulent KPC, untreatable E. coli in the community
-
-
Most children presenting for care related to fever at two Tanzanian outpatient clinics had acute respiratory infections. Malaria accounted for "only" 11% of diagnoses and typhoid fever for 4%.
-
Posaconazole oral suspension (Noxafil® oral suspension, Merck) has been, for several years, indicated for treatment of orophayngeal candidiasis as well as for prophylaxis of invasive Aspergillus and Candida infections in patients at risk. Posaconazole delayed-release tablets (Noxafil® delayed-release tablets, Merck) were recently FDA-approved for prophylaxis of invasive Aspergillus and Candida infections in immunocompromised patients 13 years of age and older.